Healthcare-associated Staphylococcus aureus bloodstream infection: Length of stay, attributable mortality, and additional direct costs

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 6, 2012, Pages 503-509

  Primo, Mariusa Gomes Borges ^a   Guilarde, Adriana Oliveira ^a   Martelli, Celina M Turchi ^a   Batista, Lindon Johnson de Abreu ^a   Turchi, Marília Dalva ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Attributable mortality; Bloodstream infection; Extra costs; Length of stay; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; METRONIDAZOLE; OXACILLIN; SULTAMICILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BLOODSTREAM INFECTION; BRAZIL; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG COST; FEMALE; HEALTH CARE COST; HEALTHCARE ASSOCIATED STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTION; HOSPITAL INFORMATION SYSTEM; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; RANK SUM TEST; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BRAZIL; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITAL COSTS; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84870440899     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.10.001     Document Type: Article

References (37)

1. Pittet D., Wenzel R.P. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995, 155:1177-1184.
2. Correa L., Pittet D. Problems and solutions in hospital-acquired bacteraemia. J Hosp Infect 2000, 46:89-95.
3. Bearman G.M.L., Wenzel R.P. Bacteremias: a leading cause of death. Arch Med Res 2005, 36:646-659.
4. Pien B.C., Sundaram P., Raoof N., et al. The clinical and prognostic importance of positive blood cultures in adults. Am J Med 2010, 123:819-828.
5. Klevens R.M., Edwards J.R., Richards C.L., et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007, 122:160-166.
6. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601.
7. Jarvis W.R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996, 17:552-557.
8. Orsi G.B., Di Stefano L., Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002, 23:190-197.
9. Rosenthal V.D., Guzman S., Migone O., Crnich C.J. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003, 31:475-480.
10. Reed S.D., Friedman J.Y., Engemann J.J., et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005, 26:175-183.
11. Pirson M., Dramaix M., Struelens M., Riley T.V., Leclercq P. Costs associated with hospital-acquired bacteraemia in a Belgian hospital. J Hosp Infect 2005, 59:33-40.
12. Blot S.I., Depuydt P., Annemans L., et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005, 41:1591-1598.
13. Thompson D.S. Estimates of the rate of acquisition of bacteraemia and associated excess mortality in a general intensive care unit: a 10 year study. J Hosp Infect 2008, 69:56-61.
14. Kilgore M., Brossette S. Cost of bloodstream infections. Am J Inf Control 2008, 36. S172.e1-S172.e3.
15. Kothari A., Sagar V., Ahluwalia V., Pillai B.S., Madan M. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study. J Hosp Infect 2009, 71:143-148.
16. Tacconelli E., Smith G., Hieke K., Lafuma A., Bastide P. Epidemiology, medical outcomes and costs of catheter-related boodstream infections in intensive care units of four European countries: literature and registry-based estimates. J Hosp Infect 2009, 72:97-103.
17. Vrijens F., Hulstaert F., Van de Sande S., Devriese S., Morales I., Parmentier Y. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increasing length to stay and healthcare costs. J Hosp Infect 2010, 75:158-162.
18. Niven D.J., Fick G.H., Kirkpatrick A.W., Grant V., Laupland K.B. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury. J Hosp Infect 2010, 76:296-299.
19. Burns A., Bowers L., Pak N., Wignall J., Roberts S. The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital. N Z Med J 2010, 123:17-24.
20. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
21. Guilarde A.O., Turchi M.D., Martelli C.M.T., Primo M.G.B., Batista L.J.A. Bacteremias at a teaching hospital: etiology, antimicrobial susceptibility pattern and risk factors for mortality. Rev Assoc Med Bras 2007, 53:34-38.
22. Laupland K.B., Zigun D.A., Davies H.D., Church D.L., Louie T.J., Doing C.J. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: incidence, risk factors, and associated mortality rate. Crit Care Med 2002, 30:2462-2467.
23. Sader H.S., Jones R.N., Andrade-Baiocchi S., Biedenbach D.J. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2003, 44:273-280.
24. Lambert M.L., Suetens C., Savey A., et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011, 11:30-38.
25. Guilarde A.O., Turchi M.D., Martelli C.M.T., Primo M.G.B. Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. J Hosp Infect 2006, 63:330-336.
26. Conterno L.O., Wey S.B., Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998, 19:32-37.
27. Rubio-Terrés C., Garau J., Grau S., Martinez-Martinez L. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study. Clin Microbiol Infect 2010, 16:722-728.
28. Harbarth S., Rustchmam O., Sudre P., Pittet D. Impact of methicillin resistance on the outcome of patients witch bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998, 158:182-189.
29. Crosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
30. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
31. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
32. McCabe W.R., Jackson G.G. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962, 110:847-855.
33. Paim J., Travassos C., Almeida C., Bahia L., Macinko J. The Brazilian health system: history, advances, and challenges. Lancet 2011, 377:1778-1797.
34. Verbrugh H.A. Impact of methicillin-resistant Staphylococcus aureus infection on morbidity and costs in healthcare facilities. Infection Control Hosp Epidemiol 2006, 27:994-995.
35. Barnett A.G., Graves N., Rosenthal V.D., Salomão R., Rangel-Frausto M.S. Excess length of stay due to a central line associated blood stream infections in intensive care units in Argentina, Brazil and Mexico. Infect control Hosp Epidemiolol 2010, 31:1106-1114.
36. Köck R., Becker K., Cookson B., et al. Methicilin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010, 15:1-9.
37. Hawkey P.M. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008, 62:i1-i9.